KOPRAN
Small Cap BSE: 524280 NSE: KOPRAN
₹153.7
-8.1 (-5.01%)
As on 30 September, 2022 | 02:47

Kopran Share Price

Kopran Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in KOPRAN

Start SIP

Kopran Share Returns

  • Over 1 Month -16.87%
  • Over 3 Month -25.06%
  • Over 6 Month -46.32%
  • Over 1 Year -22.51%

Kopran Key Statistics

P/E Ratio 11.9
PEG Ratio 0.7
Market Cap Cr 741
Price to Book Ratio 1.7
EPS 2.4
Dividend 2
Relative Strength Index 28.51
Money Flow Index 49.53
MACD Signal -6.59
Average True Range 7.84

Kopran Investment Rating

  • Master Rating:
  • Kopran has an operating revenue of Rs. 522.92 Cr. on a trailing 12-month basis. An annual revenue de-growth of -4% needs improvement, Pre-tax margin of 17% is great, ROE of 14% is good. The company has a reasonable debt to equity of 4%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 90 which is a GREAT score indicating consistency in earnings, a RS Rating of 2 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D- which indicates heavy supply, Group Rank of 125 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of D is close to being the worst. Institutional holding has remained stable in the last reported quarter. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Kopran Financials
IndicatorJun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021
Oper Rev Qtr Cr 706455562962
Operating Expenses Qtr Cr 645851522955
Operating Profit Qtr Cr 673517
Depreciation Qtr Cr 111111
Interest Qtr Cr 011111
Tax Qtr Cr 121102
Net Profit Qtr Cr 452416

Kopran Technicals

EMA & SMA

Current Price
153.7
-8.1 (-5.01%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • 170.74
  • 50 Day
  • 183.72
  • 100 Day
  • 203.37
  • 200 Day
  • 245.68
  • 20 Day
  • 172.2
  • 50 Day
  • 186.65
  • 100 Day
  • 199.24
  • 200 Day
  • 246.01

Kopran Resistance and Support

PIVOT
₹162.42
Resistance
First Resistance 166.19
Second Resistance 170.57
Third Resistance 174.34
RSI 28.51
MFI 49.53
MACD Single Line -6.59
MACD -7.77
Support
First Resistance 158.04
Second Resistance 154.27
Third Resistance 149.89

Kopran Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 159,082 8,706,558 54.73
Week 172,848 6,616,606 38.28
1 Month 126,185 6,622,214 52.48
6 Month 142,038 6,988,275 49.2

Kopran Result Highlights

Kopran Synopsis

NSE-Medical-Diversified

Kopran Ltd is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 204.52 Cr. and Equity Capital is Rs. 48.21 Cr. for the Year ended 31/03/2022. Kopran Ltd. is a Public Limited Listed company incorporated on 26/04/1958 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24230MH1958PLC011078 and registration number is 011078.
Market Cap 741
Sales 245
Shares in Float 2.70
No of funds 17
Yield 1.95
Book Value 1.96
U/D Vol ratio 0.6
LTDebt / Equity 1
Alpha -0.06
Beta 1.19

Kopran

Owner NameJun-22Mar-22Jan-22Dec-21
Promoters 44.25%44.25%44.25%
Mutual Funds
Insurance Companies 0.14%0.14%0.14%
Foreign Portfolio Investors 0.5%0.53%0.62%
Financial Institutions/ Banks
Individual Investors 39.89%39.78%40.67%
Others 15.22%15.3%14.32%

Kopran Management

Name Designation
Mr. Susheel G Somani Chairman
Mr. Surendra Somani Executive Vice Chairman
Mr. Adarsh Somani Director
Mr. Varun Somani Director
Dr. Siddhan Subramanian Independent Director
Dr. Sunita Banerji Independent Director
Mrs. Mamta Biyani Independent Director
Mr. Narayan Atal Independent Director

Kopran Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Kopran Corporate Action

Date Purpose Remarks
2022-08-10 Quarterly Results
2022-05-27 Audited Results & Final Dividend
2022-02-03 Quarterly Results
2021-10-27 Quarterly Results
2021-08-06 Quarterly Results

Kopran MF Shareholding

Name Amount(cr)
Motilal Oswal S&P BSE Healthcare ETF 6

Kopran FAQs

What is Share Price of Kopran ?

Kopran share price is ₹153 As on 30 September, 2022 | 02:33

What is the Market Cap of Kopran ?

The Market Cap of Kopran is ₹741 Cr As on 30 September, 2022 | 02:33

What is the P/E ratio of Kopran ?

The P/E ratio of Kopran is 11.9 As on 30 September, 2022 | 02:33

What is the PB ratio of Kopran ?

The PB ratio of Kopran is 1.7 As on 30 September, 2022 | 02:33

Q1FY23